175 related articles for article (PubMed ID: 35477539)
41. [Relationship between the expression of DDX39 protein and prognosis of colorectal cancer].
Ma J; Chang W; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Mar; 21(3):336-341. PubMed ID: 29577224
[TBL] [Abstract][Full Text] [Related]
42. Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer.
Chen Y; Zhang L; Liu W; Liu X
Biomed Res Int; 2015; 2015():589301. PubMed ID: 26609529
[TBL] [Abstract][Full Text] [Related]
43. Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.
Mlecnik B; Bifulco C; Bindea G; Marliot F; Lugli A; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Lafontaine L; Bruni D; Lanzi A; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Muşină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Fox BA; Pagès F; Galon J
J Clin Oncol; 2020 Nov; 38(31):3638-3651. PubMed ID: 32897827
[TBL] [Abstract][Full Text] [Related]
44. Identification of colonic fibroblast secretomes reveals secretory factors regulating colon cancer cell proliferation.
Chen SX; Xu XE; Wang XQ; Cui SJ; Xu LL; Jiang YH; Zhang Y; Yan HB; Zhang Q; Qiao J; Yang PY; Liu F
J Proteomics; 2014 Oct; 110():155-71. PubMed ID: 25118038
[TBL] [Abstract][Full Text] [Related]
45. Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.
Derangère V; Lecuelle J; Lepage C; Aoulad-Ben Salem O; Allatessem BM; Ilie A; Bouché O; Phelip JM; Baconnier M; Pezet D; Sebbagh V; Terrebonne E; Bouard G; Jooste V; Bouvier AM; Molimard C; Monnien F; Gonzalez D; Le Malicot K; Rageot D; Truntzer C; Bibeau F; Ghiringhelli F;
Eur J Cancer; 2022 Sep; 172():221-230. PubMed ID: 35785606
[TBL] [Abstract][Full Text] [Related]
46. Lumican and versican are associated with good outcome in stage II and III colon cancer.
de Wit M; Belt EJ; Delis-van Diemen PM; Carvalho B; Coupé VM; Stockmann HB; Bril H; Beliën JA; Fijneman RJ; Meijer GA
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S348-59. PubMed ID: 22711178
[TBL] [Abstract][Full Text] [Related]
47. Tumor-stroma ratio predicts recurrence in patients with colon cancer treated with neoadjuvant chemotherapy.
Hansen TF; Kjær-Frifeldt S; Lindebjerg J; Rafaelsen SR; Jensen LH; Jakobsen A; Sørensen FB
Acta Oncol; 2018 Apr; 57(4):528-533. PubMed ID: 28980848
[TBL] [Abstract][Full Text] [Related]
48. Confirmation of a metastasis-specific microRNA signature in primary colon cancer.
Coebergh van den Braak RRJ; Sieuwerts AM; Lalmahomed ZS; Smid M; Wilting SM; Bril SI; Xiang S; van der Vlugt-Daane M; de Weerd V; van Galen A; Biermann K; van Krieken JHJM; Kloosterman WP; Foekens JA; ; Martens JWM; IJzermans JNM
Sci Rep; 2018 Mar; 8(1):5242. PubMed ID: 29588449
[TBL] [Abstract][Full Text] [Related]
49. Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer.
Mezheyeuski A; Hrynchyk I; Herrera M; Karlberg M; Osterman E; Ragnhammar P; Edler D; Portyanko A; Ponten F; Sjöblom T; Glimelius B; Östman A
Br J Cancer; 2019 Aug; 121(4):303-311. PubMed ID: 31289351
[TBL] [Abstract][Full Text] [Related]
50. Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.
Giráldez MD; Lozano JJ; Cuatrecasas M; Alonso-Espinaco V; Maurel J; Mármol M; Hörndler C; Ortego J; Alonso V; Escudero P; Ramírez G; Petry C; Lasalvia L; Bohmann K; Wirtz R; Mira A; Castells A
Int J Cancer; 2013 Mar; 132(5):1090-7. PubMed ID: 22833293
[TBL] [Abstract][Full Text] [Related]
51. Intratumoral stromal morphometry predicts disease recurrence but not response to 5-fluorouracil-results from the QUASAR trial of colorectal cancer.
Hutchins GGA; Treanor D; Wright A; Handley K; Magill L; Tinkler-Hundal E; Southward K; Seymour M; Kerr D; Gray R; Quirke P;
Histopathology; 2018 Feb; 72(3):391-404. PubMed ID: 28746977
[TBL] [Abstract][Full Text] [Related]
52. Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth.
Gerling M; Büller NV; Kirn LM; Joost S; Frings O; Englert B; Bergström Å; Kuiper RV; Blaas L; Wielenga MC; Almer S; Kühl AA; Fredlund E; van den Brink GR; Toftgård R
Nat Commun; 2016 Aug; 7():12321. PubMed ID: 27492255
[TBL] [Abstract][Full Text] [Related]
53. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
54. Snail1 protein in the stroma as a new putative prognosis marker for colon tumours.
Francí C; Gallén M; Alameda F; Baró T; Iglesias M; Virtanen I; García de Herreros A
PLoS One; 2009; 4(5):e5595. PubMed ID: 19440385
[TBL] [Abstract][Full Text] [Related]
55. CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
Dalerba P; Sahoo D; Paik S; Guo X; Yothers G; Song N; Wilcox-Fogel N; Forgó E; Rajendran PS; Miranda SP; Hisamori S; Hutchison J; Kalisky T; Qian D; Wolmark N; Fisher GA; van de Rijn M; Clarke MF
N Engl J Med; 2016 Jan; 374(3):211-22. PubMed ID: 26789870
[TBL] [Abstract][Full Text] [Related]
56. The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review.
Kramer CJH; Vangangelt KMH; van Pelt GW; Dekker TJA; Tollenaar RAEM; Mesker WE
Breast Cancer Res Treat; 2019 Jan; 173(1):55-64. PubMed ID: 30302588
[TBL] [Abstract][Full Text] [Related]
57. Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study.
Reichling C; Taieb J; Derangere V; Klopfenstein Q; Le Malicot K; Gornet JM; Becheur H; Fein F; Cojocarasu O; Kaminsky MC; Lagasse JP; Luet D; Nguyen S; Etienne PL; Gasmi M; Vanoli A; Perrier H; Puig PL; Emile JF; Lepage C; Ghiringhelli F
Gut; 2020 Apr; 69(4):681-690. PubMed ID: 31780575
[TBL] [Abstract][Full Text] [Related]
58. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
[TBL] [Abstract][Full Text] [Related]
59. The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial.
Huijbers A; van Pelt GW; Kerr RS; Johnstone EC; Tollenaar RAEM; Kerr DJ; Mesker WE
J Surg Oncol; 2018 Apr; 117(5):1043-1048. PubMed ID: 29448309
[TBL] [Abstract][Full Text] [Related]
60. The Interleukin 22 Pathway Interacts with Mutant KRAS to Promote Poor Prognosis in Colon Cancer.
McCuaig S; Barras D; Mann EH; Friedrich M; Bullers SJ; Janney A; Garner LC; Domingo E; Koelzer VH; Delorenzi M; Tejpar S; Maughan TS; West NR; Powrie F
Clin Cancer Res; 2020 Aug; 26(16):4313-4325. PubMed ID: 32430479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
